Status:
COMPLETED
Attention-Deficit Hyperactivity Disorder (ADHD) Rating Scale and Epilepsy
Lead Sponsor:
Hospices Civils de Lyon
Conditions:
Epilepsy
Eligibility:
All Genders
6-16 years
Phase:
NA
Brief Summary
The cognitive and psychiatric comorbidities are crucial endpoints in epileptic patients. Among these comorbidities, the Attention-Deficit Hyperactivity Disorder (ADHD) accounts for one of the most imp...
Eligibility Criteria
Inclusion
- children aged 6 to 15 years and 11 months;
- male or female;
- with a diagnosis of ADHD : predominantly inattentive or combined hyperactive-impulsive and inattentive according to the DSM IV criteria;
- children who agreed to participate to the protocol and whose legal representatives have clearly expressed their non-opposition to participate.
Exclusion
- Patients below 6 years old or patients older than 16 years;
- with a diagnosis of ADHD predominantly hyperactive-impulsive subtype ADHD according to the DSM IV criteria;
- mental retardation defined by a score \< 70 at the verbal comprehension index and the perceptual reasoning score of the Wechsler Intelligence Scale for Children - Fourth Edition (WISC-IV)
- established diagnosis of any psychiatric co-morbidity other than ADHD according to the DSM IV criteria (pervasive developmental disorders including autism, bipolar disorder, psychotic disorder).
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT01482026
Start Date
November 1 2011
End Date
December 1 2015
Last Update
September 9 2025
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Service de Neurologie pédiatrique, CHU d'Amiens
Amiens, France, 80054
2
Service de Neurologie Pédiatrique, CHU d'Angers
Angers, France, 49033
3
Service de Neurologie pédiatrique, CHU de Besançon
Besançon, France, 25030
4
Unité de Neurologie de l'Enfant et de l'Adolescent, Hôpital Pellegrin
Bordeaux, France, 33076